Breaking News Instant updates and real-time market news.

TM

Toyota

$139.52

0.12 (0.09%)

10:09
01/23/18
01/23
10:09
01/23/18
10:09

Toyota surpasses 3,000 Mirai hydrogen fuel cell vehicle sales in California

The Toyota Mirai, one of the world's first mass-produced hydrogen fuel cell electric vehicles, has surpassed 3,000 sales in the Golden State. Having reached this new milestone, Mirai make up more than 80% of all hydrogen fuel cell vehicles in the United States. "Toyota remains at the forefront of developing and deploying hydrogen fuel cell technology, and we believe strongly in its potential to help realize a more sustainable and zero-emissions society," said Bob Carter, EVP, Toyota Motor North America, Inc. "From our success in launching the Mirai to our work in building the world's first megawatt-scale carbonate fuel cell power generation plant, Toyota is proud to bring to market new uses for this versatile technology." The Toyota Mirai, a four-door, mid-size sedan, is a zero-emission hydrogen vehicle with an EPA estimated driving range rating of 312 miles and 67 mpge city/highway/combined.

  • 25

    Jan

TM Toyota
$139.52

0.12 (0.09%)

08/24/17
RBCM
08/24/17
NO CHANGE
RBCM
Demand for Nvidia gaming chips remains strong, says RBC Capital
After conducting checks and reviewing Nvidia's (NVDA) 10-Q, RBC Capital analysts Mitch Steves and Amit Daryanani say that demand for Nvidia's gaming chips "remains healthy" in the midst of strong demand from crypto-currency miners. The analysts add that the company's new deal with Toyota (TM) should boost its selling volumes in 2018-2019, and cause its average selling prices to rise towards the end of that period. They add that sales of the company's Volta chip "are beginning to ramp." The analysts keep an Outperform rating on Nvidia.
09/21/17
RBCM
09/21/17
NO CHANGE
RBCM
Nvidia likely to continue partnering with Tesla, says RBC Capital
After CNBC and other media outlets reported that Tesla (TSLA) would work with AMD (AMD) to improve its self-driving car chips, RBC Capital analyst Mitch Steves expects Nvidia to continue to work with Tesla and remain the dominant chip provider to the automaker. He expects "similar dynamics" to play out in the data center space, with AMD "winning some share" in the sector, and Nvidia "remaining as the de-facto standard and market share leader." He notes that Toyota (TM) and Uber both use Nvidia's technology, and he does not expect the loss of share at Tesla to impact the chip maker over the long-term. He keeps an Outperform rating on Nvidia.
10/04/17
SBSH
10/04/17
UPGRADE
SBSH
Buy
Toyota upgraded to Buy from Neutral at Citi
Citi analyst Arifumi Yoshida upgraded Toyota Motor to Buy and raised his price target for the shares to 8,800 yen from 6,800 yen. The analyst believes Toyota's market share in the U.S. is recovering and thinks its development trends in all-solid-state batteries can drive multiple expansion.
10/04/17
10/04/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Toyota (TM) upgraded to Buy from Neutral at Citi with analyst Arifumi Yoshida saying he believes Toyota's market share in the U.S. is recovering and thinks its development trends in all-solid-state batteries can drive multiple expansion. 2. Sanchez Energy (SN) upgraded to Neutral from Sell at Seaport Global with analyst Mike Kelly citing valuation. 3. Jack in the Box (JACK) upgraded to Outperform from Market Perform at Telsey Advisory with analyst Bob Derrington saying the company is "increasing its focus" on "improving its business trends." 4. Lennar (LEN) upgraded to Buy from Neutral at MKM Partners with analyst Megan McGrath saying she believes that its margins are stabilizing. 5. Dollar Tree (DLTR) upgraded to Buy from Neutral at Cleveland Research with analyst Scott Bender saying checks indicate Family Dollar trends have improved "noticeably" in the third quarter driven by a combination of company specific initiatives including remodels, merchandising changes, and operational improvements, and a general improvement in dollar channel sales trends. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

SSKN

Strata Skin Sciences

$2.11

0.09 (4.46%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Strata announces 510(k) submission for Multi-Micro Dose tip accessory »

STRATA Skin Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RTN

Raytheon

$202.60

1.06 (0.53%)

08:05
06/19/18
06/19
08:05
06/19/18
08:05
Hot Stocks
Raytheon awarded $161M contract from U.S. Army »

Raytheon was awarded a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LASR

nLight

$38.51

-0.05 (-0.13%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
nLight analyst commentary  »

nLight price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIBB

Hibbett Sports

$21.70

-0.1 (-0.46%)

08:04
06/19/18
06/19
08:04
06/19/18
08:04
Recommendations
Hibbett Sports analyst commentary  »

Hibbett Sports weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FBNK

First Connecticut

$26.05

0.15 (0.58%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
Breaking Hot Stocks news story on First Connecticut »

First Connecticut trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PTC

PTC

$97.80

2.93 (3.09%)

, ANSS

Ansys

$177.91

0.17 (0.10%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Recommendations
PTC, Ansys, Rockwell Automation analyst commentary  »

PTC price target raised…

PTC

PTC

$97.80

2.93 (3.09%)

ANSS

Ansys

$177.91

0.17 (0.10%)

ROK

Rockwell Automation

$175.40

-2.19 (-1.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

NCR

NCR Corp.

$32.23

0.06 (0.19%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Hot Stocks
NCR Corp. announces strategic alliance with TCS »

NCR Corp. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DEA

Easterly Government Properties

$20.17

0.14 (0.70%)

08:03
06/19/18
06/19
08:03
06/19/18
08:03
Syndicate
Easterly Government Properties 18M share Spot Secondary priced at $19.25 »

The company increased the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

CLBS

Caladrius

$4.05

-0.015 (-0.37%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Caladrius receives FDA RMAT designation for CD34+ cell therapy »

Caladrius Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CBPO

China Biologic

$99.29

17.39 (21.23%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
China Biologic receives acquisition proposal from CCRE for $110 cash per share »

China Biologic announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XPO

XPO Logistics

$114.10

0.215 (0.19%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Initiation
XPO Logistics initiated  »

XPO Logistics resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TREX

Trex Company

$64.61

1.675 (2.66%)

08:02
06/19/18
06/19
08:02
06/19/18
08:02
Hot Stocks
Trex Company announces effectiveness of 2-for-1 stock split »

Trex Company announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

G

Genpact

$30.84

-0.095 (-0.31%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Hot Stocks
Genpact awarded patent for natural language understanding by USPTO »

Genpact announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ULH

Universal Logistics

$26.50

0.15 (0.57%)

08:01
06/19/18
06/19
08:01
06/19/18
08:01
Initiation
Universal Logistics initiated  »

Universal Logistics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

LSTR

Landstar System

$115.30

0.25 (0.22%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Landstar System initiated  »

Landstar System resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$49.15

0.3 (0.61%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Recommendations
Mirati Therapeutics analyst commentary  »

Mirati Therapeutics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

  • 28

    Jun

ECHO

Echo Global

$30.40

-0.15 (-0.49%)

08:00
06/19/18
06/19
08:00
06/19/18
08:00
Initiation
Echo Global initiated  »

Echo Global resumed with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 20

    Jun

CHRW

C.H. Robinson

$90.67

0.57 (0.63%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Initiation
C.H. Robinson initiated  »

C.H. Robinson resumed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

TTPH

Tetraphase

$4.20

-0.05 (-1.18%)

07:59
06/19/18
06/19
07:59
06/19/18
07:59
Conference/Events
Tetraphase has a conference call hosted by SunTrust »

SunTrust will host a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

  • 25

    Jun

  • 28

    Aug

BTE

Baytex Energy

$3.40

-0.47 (-12.16%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Upgrade
Baytex Energy rating change  »

Baytex Energy upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.05

(0.00%)

07:56
06/19/18
06/19
07:56
06/19/18
07:56
Recommendations
Snap analyst commentary  »

Snap survey shows usage…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:55
06/19/18
06/19
07:55
06/19/18
07:55
General news
U.S. chain store sales rose 1.4% in the week ended June 16 »

U.S. chain store sales…

HSGX

Histogenics

$2.87

-0.1 (-3.37%)

07:55
06/19/18
06/19
07:55
06/19/18
07:55
Conference/Events
Histogenics to host investor day »

Investor Day to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

TDG

TransDigm

$340.12

0.06 (0.02%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Recommendations
TransDigm analyst commentary  »

TransDigm poised to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

, BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

07:54
06/19/18
06/19
07:54
06/19/18
07:54
Downgrade
Madrigal Pharmaceuticals, Bristol-Myers, Nektar rating change  »

Madrigal cut to In Line…

MDGL

Madrigal Pharmaceuticals

$306.24

6.23 (2.08%)

BMY

Bristol-Myers

$53.65

-1.155 (-2.11%)

NKTR

Nektar

$58.40

0.545 (0.94%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 10

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.